My bookmarksSign up free

Commission Implementing Regulation (EU) 2019/1589 of 26 September 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (Text with EEA relevance.)

Commission Implementing Regulation (EU) 2019/1589 of 26 September 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (Text with EEA relevance.)

Implementing Regulation (EU) 2019/1589 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2020’; (2) in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2020’; (3) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2020’; (4) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2020’; (5) in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2020’; (6) in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2020’; (7) in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2020’; (8) in the sixth column, expiration of approval, of row 105, Thiophanate-methyl, the date is replaced by ‘31 October 2020’; (9) in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2020’; (10) in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2020’; (11) in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2020’; (12) in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2020’; (13) in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2020’; (14) in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2020’; (15) in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2020’; (16) in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2020’; (17) in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2020’; (18) in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2020’; (19) in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2020’; (20) in the sixth column, expiration of approval, of row 174, Diflubenzuron, the date is replaced by ‘31 December 2020’; (21) in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2020’; (22) in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2020’; (23) in the sixth column, expiration of approval, of row 179, Pyriproxyfen, the date is replaced by ‘31 December 2020’; (24) in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2020’; (25) in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2020’; (26) in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2020’; (27) in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2020’; (28) in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2020’; (29) in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2020’.

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next